Elon Musk Got Twitter’s Data Dump, Next Comes the Hard Part
Elon Musk has gained access to the Twitter data that he said was needed to complete his $44 billion acquisition, but data scientists and specialists doubt the stream will provide…
Power Bi Blog
Elon Musk has gained access to the Twitter data that he said was needed to complete his $44 billion acquisition, but data scientists and specialists doubt the stream will provide…
The Committee on Foreign Investment in the U.S. is reviewing Ericsson proposed $6.2 billion acquisition of Vonage Holdings Corp., Ericsson said, adding another regulatory challenge for the Swedish telecom-equipment giant…
JetBlue Airways and Frontier Airlines jostled for last-minute support among Spirit Airlines shareholders ahead of their vote this week in what has become a hotly contested airline-merger fight. Spirit on…
Updated June 28, 2022 4:11 pm ET Listen to article (2 minutes) Creative Artists Agency completed its acquisition of ICM Partners, a deal that combines two of the entertainment industry’s…
Volkswagen has agreed to sell a minority stake in its U.S. electric-vehicle charging business to Siemens in a transaction that provides $450 million in new money and values the charging…
JetBlue Airways Corp. isn’t backing down in its fight to buy Spirit Airlines Inc. raising its offer yet again in an effort to outmaneuver rival Frontier Airlines. JetBlue on Monday…
Some of the nation’s biggest retailers are rationing over-the-counter emergency contraceptive pills as demand spikes following the Supreme Court ruling overturning a constitutional right to abortion. CVS Health Walmart and…
Volkswagen is close to selling a minority stake in its U.S. electric-vehicle charge business to an arm of Siemens a deal that would value the network at more than $2…
HONG KONG—One of China’s top lithium producers began marketing what is expected to be Hong Kong’s largest initial public offering so far this year, braving recent market volatility to test…
Merck & Co. is eyeing a purchase of biotech Seagen according to people familiar with the matter, a move that would beef up the pharmaceutical giant’s cancer-drug portfolio. Talks have…